SIGMA LABS, INC (OTCMKTS:SGLB) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On June 12, 2017, Sam Bell resigned from the board of directors (the “Board”), Audit Committee of the Board (the "Audit Committee"), Compensation Committee of the Board, and the Nominating and Corporate Governance Committee of the Board, of Sigma Labs, Inc. (“Sigma”). Mr. Bell was an independent director of Sigma and chairman of the Audit Committee, and as a result of the resignation of Mr. Bell, Sigma no longer complies with Nasdaq’s audit committee requirements as set forth in Nasdaq Listing Rule 5605 because the Audit Committee is not comprised of at least three independent directors.

On June 12, 2017, in accordance with Nasdaq Listing Rules, Sigma notified Nasdaq of Mr. Bell’s resignation and the resulting non-compliance with Nasdaq Listing Rule 5605. On June 13, 2017, Sigma received a notice from Nasdaq acknowledging the fact that Sigma does not meet the requirements of Nasdaq Listing Rule 5605. 

In accordance with Nasdaq Listing Rule 5605(c)(4), to regain compliance with Nasdaq Listing Rules, Sigma (i) has until the earlier of its next annual shareholders’ meeting or June 12, 2018, or (ii) if Sigma’s next annual shareholders’ meeting is held before December 11, 2017, then Sigma must evidence compliance no later than December 11, 2017.

The Board intends to identify a candidate to replace Mr. Bell and to appoint a new director who satisfies the requirements of the Nasdaq Listing Rules prior to the expiration of the applicable cure period.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As described above in Item 3.01, on June 12, 2017, Sam Bell resigned from the Board, Audit Committee, Compensation Committee of the Board, and the Nominating and Corporate Governance Committee of the Board, of Sigma.

About SIGMA LABS, INC (OTCMKTS:SGLB)

Sigma Labs, Inc. is a technology company that specializes in the development and commercialization of manufacturing and materials technologies. The Company’s principal business activities include the development of its In-Process Quality Assurance (IPQA) suite of technologies and the commercialization of both its IPQA and materials-related suite of technologies, with its focus on three-dimensional printing (3DP) industry. It is engaged in a range of activities in which it seeks to commercialize technologies and products in various industry sectors, such as aerospace and defense manufacturing; bio-medical manufacturing; automotive manufacturing, and other markets. It offers PrintRite3D SENSORPAK, which is an auxiliary sensor and hardware kit; PrintRite3D INSPECT, which is a software that verifies quality layer by layer, and PrintRite3D CONTOUR, which is a software that assures the as-built geometry. Its other software modules include PrintRite3D THERMAL and PrintRite3D ANALYTICS.